Ono T, Akita M, Tsujii T, Seno S
Division of Pathology, Shigei Medical Research Institute, Okayama, Japan.
Cell Struct Funct. 1989 Feb;14(1):61-74. doi: 10.1247/csf.14.61.
In order to reveal the pathway of iron release from macrophages, a 59Fe-labelled ferric hydroxide-potassium polyvinyl sulfate complex (Fe-PVS) was injected intravenously into anemic rats and the level of radioactivity in the liver, spleen, bone marrow, blood plasma and red blood cells (RBC) was estimated at various time intervals after the injection. Histochemical observation of ferric iron and ferritin in the liver was also made on anemic rats treated using unlabelled Fe-PVS. Fe-PVS injection promoted the recovery of anemia causing a rapid increase in the RBC number, with activated erythropoiesis occurring in the spleen and bone marrow. Soon after the injection, most of the radio iron was found in the liver with a small amount in the circulating erythrocytes, bone marrow and spleen. The iron level in the liver decreased gradually with a rapid increase in the iron level of the erythrocytes which reached a very high level 6 days after the 59Fe-PVS injection. Histochemical observations showed a heavy deposition of ferritin in the Kupffer cells 3 days after Fe-PVS injection. This deposition was minimized after 6 days with an increase in the level of ferritin in the parenchymal cells in the central area of acini. The level of radioferritin estimated biochemically in the nonparenchymal cell fractions of the liver revealed that the level dropped by about one third approximately 3.5 days after the Fe-PVS injection, showing the stimulated ferritin release at this stage. Results indicate that Kupffer cells in the liver play an important role in ferritin synthesis from the phagocytized iron compounds and that the iron is supplied for erythroid cell proliferation.
为了揭示铁从巨噬细胞释放的途径,将59Fe标记的氢氧化铁-聚硫酸钾复合物(Fe-PVS)静脉注射到贫血大鼠体内,并在注射后的不同时间间隔估算肝脏、脾脏、骨髓、血浆和红细胞(RBC)中的放射性水平。还对使用未标记Fe-PVS治疗的贫血大鼠进行了肝脏中铁离子和铁蛋白的组织化学观察。Fe-PVS注射促进了贫血的恢复,导致RBC数量迅速增加,脾脏和骨髓中出现活跃的红细胞生成。注射后不久,大部分放射性铁存在于肝脏中,少量存在于循环红细胞、骨髓和脾脏中。肝脏中的铁水平逐渐下降,而红细胞中的铁水平迅速上升,在注射59Fe-PVS后6天达到非常高的水平。组织化学观察显示,Fe-PVS注射后3天,库普弗细胞中铁蛋白大量沉积。6天后,随着腺泡中心区域实质细胞中铁蛋白水平的增加,这种沉积减少到最低程度。对肝脏非实质细胞部分进行生化估算的放射性铁蛋白水平显示,Fe-PVS注射后约3.5天,该水平下降了约三分之一,表明在此阶段铁蛋白释放受到刺激。结果表明,肝脏中的库普弗细胞在从吞噬的铁化合物合成铁蛋白中起重要作用,并且铁被供应用于红细胞的增殖。